A Study of Patients Who Recently Have Been Infected With HIV
Withdrawn before enrolling
Conditions studied: HIV Infections
In brief
The purpose of this study is to find out if anti-HIV drugs, taken by patients who are newly infected with HIV, can make the level of HIV in the body too low to detect. Studying patients who recently have been infected with HIV may help researchers understand how HIV infection works and how anti-HIV drugs may help these patients. Approved anti-HIV drugs can reduce the amount of HIV, but more research needs to be done in newly infected patients. This study will look at recently HIV-infected patients to study the progression of HIV disease and to see whether anti-HIV drugs can reduce the level of HIV.
Key facts
- Study ID
- NCT00006415
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 0
- Last updated by the study team
- 2015-03-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients may be eligible for this study if they:
- Have had certain tests indicating that they recently have been infected with HIV.
- Agree to use effective methods of birth control during the study and for 3 months after.
- Are at least 18 years old.
You may not qualify if…
- Patients will not be eligible for this study if they:
- Have taken anti-HIV drugs.
- Take erythropoietin, G-CSF or GM-CSF within 30 days of study entry.
- Take interferons, interleukins, cytotoxic chemotherapy, or HIV vaccines within 30 days of study entry.
- Take medications that should not be taken with their prescribed anti-HIV drugs.
- Have had radiation treatment within 30 days of study entry.
- Are pregnant or breast-feeding.
Where it is running
- Study site — Horsham, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.